25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects

Author(s): Giovanni De Pergola*, Tommaso Martino, Roberta Zupo, Domenico Caccavo, Claudio Pecorella, Silvia Paradiso, Franco Silvestris, Vincenzo Triggiani.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 19 , Issue 6 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Obesity is associated with lower serum vitamin D (25(OH)D) levels through several mechanisms. The aim of the study was to examine the possibility of a negative association between fat mass and 25(OH)D levels in a cohort of otherwise healthy overweight and obese subjects, independently of age, sex, blood pressure levels and anthropometric and metabolic parameters.

Materials and Methods: 147 overweight and obese subjects (106 women and 41 men), aged between 18 and 69 years, were enrolled into the study. All of them did not show any clinically evident metabolic or chronic diseases (i.e. hypertension, diabetes mellitus, renal failure, etc.) and did not use any kind of drug. Serum fasting levels of 25(OH)D, insulin, glucose, uric acid and lipids (triglycerides, total, HDL and LDL cholesterol) were measured. The season in which the blood samples were collected was autumn. Insulin resistance was assessed by using the Homeostasis Model Assessment (HOMA-IR). Body composition parameters (Fat Mass [FM], Fat Free Mass [FFM], body cell mass [BCM], Total Body Water [TBW]) were measured by electrical Bioimpedance Analysis (BIA). Lastly, demographic, anthropometric and clinical parameters (age, Body Mass Index [BMI], Waist Circumference [WC], Systolic (SBP) and Diastolic (DBP) blood pressure) were also assessed.

Results: 25(OH)D levels were significantly and negatively correlated with BMI (P <0.001), WC (P <0.01), DBP (P <0.05), insulin (P <0.001), HOMA-IR (P <0.01), triglycerides (P <0.01), and fat mass (P <0.001). A multivariate regression analysis was performed by considering 25(OH)D levels as the dependent variable and sex, waist circumference, fat mass, DBP, triglycerides, and insulin (or HOMAIR) as the independent ones, and 25(OH)D levels maintained a significant and independent relationship only with fat mass (negative) (P <0.01).

Conclusion: This study clearly shows that 25(OH)D circulating levels are progressively lower with the increase of fat mass, independently of sex, body fat distribution, blood pressure and insulin and metabolic parameters. These data strongly show that adipose tissue accumulation per se is absolutely the main factor responsible factor for lower 25(OH)D levels in obese subjects, possibly through sequestration of fat soluble 25(OH)D in fat mass.

Keywords: Vitamin D, fat mass, obesity, 25-hydroxyvitamin D levels, adipose tissue, blood pressure levels.

[1]
Nettore, I.C.; Albano, L.; Ungaro, P.; Colao, A.; Macchia, P.E. Sunshine vitamin and thyroid. Rev. Endocr. Metab. Disord., 2017, 18(3), 347-354.
[http://dx.doi.org/10.1007/s11154-017-9406-3] [PMID: 28092021]
[2]
Muscogiuri, G.; Mitri, J.; Mathieu, C.; Badenhoop, K.; Tamer, G.; Orio, F.; Mezza, T.; Vieth, R.; Colao, A.; Pittas, A. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur. J. Endocrinol., 2014, 171(3), R101-R110.
[http://dx.doi.org/10.1530/EJE-14-0158] [PMID: 24872497]
[3]
De Pergola, G.; Nitti, A.; Bartolomeo, N.; Gesuita, A.; Giagulli, V.A.; Triggiani, V.; Guastamacchia, E.; Silvestris, F. Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. BioMed Res. Int., 2013.2013921348
[http://dx.doi.org/10.1155/2013/921348] [PMID: 23509804]
[4]
Song, Y.; Wang, L.; Pittas, A.G.; Del Gobbo, L.C.; Zhang, C.; Manson, J.E.; Hu, F.B. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care, 2013, 36(5), 1422-1428.
[http://dx.doi.org/10.2337/dc12-0962] [PMID: 23613602]
[5]
Golzarand, M.; Shab-Bidar, S.; Koochakpoor, G.; Speakman, J. R.; Djafarian, K. Effect of vitamin D3 supplementation on blood pressure in adults: An updated meta-analysis. Nutr. Metab. Cardiovasc. Dis., 2016, 26(8), 663-673.
[http://dx.doi.org/10.1016/j.numecd.2016.04.011] [PMID: 27287826]
[6]
Pilz, S.; Tomaschitz, A.; März, W.; Drechsler, C.; Ritz, E.; Zittermann, A.; Cavalier, E.; Pieber, T.R.; Lappe, J.M.; Grant, W.B.; Holick, M.F.; Dekker, J.M. Vitamin D, cardiovascular disease and mortality. Clin. Endocrinol. (Oxf.), 2011, 75(5), 575-584.
[http://dx.doi.org/10.1111/j.1365-2265.2011.04147.x] [PMID: 21682758]
[7]
Bandera Merchan, B.; Morcillo, S.; Martin-Nuñez, G.; Tinahones, F.J.; Macías-González, M. The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences. J. Steroid Biochem. Mol. Biol., 2017, 167, 203-218.
[http://dx.doi.org/10.1016/j.jsbmb.2016.11.020] [PMID: 27913313]
[8]
Rosen, Y.; Daich, J.; Soliman, I.; Brathwaite, E.; Shoenfeld, Y. Vitamin D and autoimmunity. Scand. J. Rheumatol., 2016, 45(6), 439-447.
[http://dx.doi.org/10.3109/03009742.2016.1151072] [PMID: 27191042]
[9]
De Pergola, G.; Triggiani, V.; Bartolomeo, N.; Giagulli, V.A.; Anelli, M.; Masiello, M.; Candita, V.; De Bellis, D.; Silvestris, F. Low 25hydroxyvitamin D levels are independently associated with autoimmune thyroiditis in a cohort of apparently healthy overweight and obese subjects. Endocr. Metab. Immune Disord. Drug Targets, 2018, 18(6), 646-652.
[http://dx.doi.org/10.2174/1871530318666180406163426] [PMID: 29623823]
[10]
Lerchbaum, E.; Obermayer-Pietsch, B. Vitamin D and fertility: a systematic review. Eur. J. Endocrinol., 2012, 166(5), 765-778.
[http://dx.doi.org/10.1530/EJE-11-0984] [PMID: 22275473]
[11]
Legaki, E.; Gazouli, M. Influence of environmental factors in the development of inflammatory bowel diseases. World J. Gastrointest. Pharmacol. Ther., 2016, 7(1), 112-125.
[http://dx.doi.org/10.4292/wjgpt.v7.i1.112] [PMID: 26855817]
[12]
Di Somma, C.; Scarano, E.; Barrea, L.; Zhukouskaya, V.V.; Savastano, S.; Mele, C.; Scacchi, M.; Aimaretti, G.; Colao, A.; Marzullo, P. Vitamin D and Neurological Diseases: An Endocrine View. Int. J. Mol. Sci., 2017, 18(11)E2482
[http://dx.doi.org/10.3390/ijms18112482] [PMID: 29160835]
[13]
Pereira-Santos, M.; Costa, P.R.F.; Assis, A.M.O.; Santos, C.A.S.T.; Santos, D.B. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes. Rev., 2015, 16(4), 341-349.
[http://dx.doi.org/10.1111/obr.12239] [PMID: 25688659]
[14]
Earthman, C.P.; Beckman, L.M.; Masodkar, K.; Sibley, S.D. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int. J. Obes., 2012, 36(3), 387-396.
[http://dx.doi.org/10.1038/ijo.2011.119] [PMID: 21694701]
[15]
Gangloff, A.; Bergeron, J.; Pelletier-Beaumont, E.; Nazare, J.A.; Smith, J.; Borel, A.L.; Lemieux, I.; Tremblay, A.; Poirier, P.; Alméras, N.; Després, J.P. Effect of adipose tissue volume loss on circulating 25-hydroxyvitamin D levels: results from a 1-year lifestyle intervention in viscerally obese men. Int. J. Obes., 2015, 39(11), 1638-1643.
[http://dx.doi.org/10.1038/ijo.2015.118] [PMID: 26095245]
[16]
Mallard, S.R.; Howe, A.S.; Houghton, L.A. Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials. Am. J. Clin. Nutr., 2016, 104(4), 1151-1159.
[http://dx.doi.org/10.3945/ajcn.116.136879] [PMID: 27604772]
[17]
Di Nisio, A.; De Toni, L.; Sabovic, I.; Rocca, M.S.; De Filippis, V.; Opocher, G.; Azzena, B.; Vettor, R.; Plebani, M.; Foresta, C. Impaired release of vitamin D in dysfunctional adipose tissue: new cues on vitamin D supplementation in obesity. J. Clin. Endocrinol. Metab., 2017, 102(7), 2564-2574.
[http://dx.doi.org/10.1210/jc.2016-3591] [PMID: 28187222]
[18]
Calton, E.K.; Pathak, K.; Soares, M.J.; Alfonso, H.; Keane, K.N.; Newsholme, P.; Cummings, N.K.; Chan She Ping-Delfos, W.; Hamidi, A. Vitamin D status and insulin sensitivity are novel predictors of resting metabolic rate: a cross-sectional analysis in Australian adults. Eur. J. Nutr., 2016, 55(6), 2075-2080.
[http://dx.doi.org/10.1007/s00394-015-1021-z] [PMID: 26306671]
[19]
Golzarand, M.; Hollis, B.W.; Mirmiran, P.; Wagner, C.L.; Shab-Bidar, S. Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur. J. Clin. Nutr., 2018, 72(10), 1345-1357.
[http://dx.doi.org/10.1038/s41430-018-0132-z] [PMID: 29563638]
[20]
Friedewald, W.T.; Levy, R.I.; Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem., 1972, 18(6), 499-502.
[PMID: 4337382]
[21]
Bonora, E.; Targher, G.; Alberiche, M.; Bonadonna, R.C.; Saggiani, F.; Zenere, M.B.; Monauni, T.; Muggeo, M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 2000, 23(1), 57-63.
[http://dx.doi.org/10.2337/diacare.23.1.57] [PMID: 10857969]
[22]
Iolascon, G.; Letizia, M.G.; Fiore, P. Cisari. C.; Benedetti, M.G.; Panella, L.; De Sire, A.; Calafiore, D., Moretti, A.; Gimigliano, F. Can vitamin D deficiency influence muscle performance in post-menopausal women? A multicenter retrospective study. Eur. J. Phys. Rehabil. Med., 2018, 54(5), 676-682.
[http://dx.doi.org/10.23736/S1973-9087.17.04533-6] [PMID: 28696084]
[23]
Cefalo, C.M.A.; Conte, C.; Sorice, G.P.; Moffa, S.; Sun, V.A.; Cinti, F.; Salomone, E.; Muscogiuri, G.; Brocchi, A.A.G.; Pontecorvi, A.; Mezza, T.; Giaccari, A. Effect of vitamin D supplementation on obesity-induced insulin resistance: a double-blind, randomized, placebo-controlled trial. Obesity (Silver Spring), 2018, 26(4), 651-657.
[http://dx.doi.org/10.1002/oby.22132] [PMID: 29504254]
[24]
Mousa, A.; Naderpoor, N.; de Courten, M.P.J.; Teede, H.; Kellow, N.; Walker, K.; Scragg, R.; de Courten, B. Vitamin D supplementation has no effect on insulin sensitivity or secretion in vitamin D-deficient, overweight or obese adults: a randomized placebo-controlled trial. Am. J. Clin. Nutr., 2017, 105(6), 1372-1381.
[http://dx.doi.org/10.3945/ajcn.117.152736] [PMID: 28490514]
[25]
Skaaby, T.; Husemoen, L.L.; Martinussen, T.; Thyssen, J.P.; Melgaard, M.; Thuesen, B.H.; Pisinger, C.; Jørgensen, T.; Johansen, J.D.; Menné, T.; Carlsen, B.; Szecsi, P.B.; Stender, S.; Fenger, R.V.; Fenger, M.; Linneberg, A. Vitamin D status, filaggrin genotype, and cardiovascular risk factors: a Mendelian randomization approach. PLoS One, 2013, 8(2)e57647
[http://dx.doi.org/10.1371/journal.pone.0057647] [PMID: 23460889]
[26]
Golzarand, M.; Shab-Bidar, S.; Koochakpoor, G.; Speakman, J. R.; Djafarian, K. Effect of vitamin D3 supplementation on blood pressure in adults: An updated meta-analysis. Nutr. Metab. Cardiovasc. Dis., 2016, 26(8), 663-673.
[http://dx.doi.org/10.1016/j.numecd.2016.04.011] [PMID: 27287826]
[27]
Cesareo, R.; Attanasio, R.; Caputo, M.; Castello, R.; Chiodini, I.; Falchetti, A.; Guglielmi, R.; Papini, E.; Santonati, A.; Scillitani, A.; Toscano, V.; Triggiani, V.; Vescini, F.; Zini, M. Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults. Nutrients, 2018, 10(5)E546
[http://dx.doi.org/10.3390/nu10050546] [PMID: 29702603]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 6
Year: 2019
Page: [838 - 844]
Pages: 7
DOI: 10.2174/1871530319666190122094039
Price: $58

Article Metrics

PDF: 25
HTML: 2
EPUB: 1
PRC: 1